SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

2.

BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring

3.

Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers

4.

In cancer survivors, loneliness is associated with a higher risk of death.

5.

O. A. J. Simpson passes away from cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot